DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Dawwas GK, Brown J, Dietrich E, Park H.
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis.
Lancet Haematol 2019;
6 (01) e20-e28
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.